Literature DB >> 3987804

Effect of concomitant food intake on absorption kinetics of erythromycin in healthy volunteers.

T Hovi, M Heikinheimo.   

Abstract

The steady state absorption of erythromycin from enteric-coated pellets of erythromycin base was compared with that from enteric-coated tablets in a randomized, two-way cross-over study in 24 healthy adult volunteers. A higher mean individual peak concentration (p less than 0.01), and a greater mean area under the serum concentration-time (0-8 h) curve (AUC, p less than 0.01) was produced by the enteric-coated pellets, when the preparations were administered 1 hour before breakfast. No significant differences in the kinetic parameters between the two preparations were observed when they were taken during a non-standardized breakfast, as concomitant food intake was found to reduce both the peak levels and the AUC-values (p less than 0.01) produced by the pelleted preparation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3987804     DOI: 10.1007/bf00609699

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

1.  Studies on absorption of a newly developed enteric-coated erythromycin base.

Authors:  P J McDonald; L E Mather; M J Story
Journal:  J Clin Pharmacol       Date:  1977-10       Impact factor: 3.126

2.  Pharmacokinetics of a new, microencapsulated erythromycin base after repeated oral doses.

Authors:  K Josefsson; M Steinbakk; T Bergan; T Midtvedt; L Magni
Journal:  Chemotherapy       Date:  1982       Impact factor: 2.544

Review 3.  The influence of food on the absorption of antimicrobial agents.

Authors:  P G Welling; F L Tse
Journal:  J Antimicrob Chemother       Date:  1982-01       Impact factor: 5.790

4.  Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base.

Authors:  K Josefsson; T Bergan; L Magni
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

5.  Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.

Authors:  T Hovi; K Josefsson; O V Renkonen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.

Authors:  A R DiSanto; D J Chodos
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

7.  The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.

Authors:  D Clayton; A Leslie
Journal:  J Int Med Res       Date:  1981       Impact factor: 1.671

8.  The influence of food on the bioavailability of new formulations of erythromycin stearate and base.

Authors:  J Rutland; N Berend; G E Marlin
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

  8 in total
  3 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

3.  Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.

Authors:  D Croteau; M G Bergeron; M LeBel
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.